NASDAQ:CERT Certara (CERT) Stock Price, News & Analysis $10.55 -0.13 (-1.22%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$10.58 +0.03 (+0.32%) As of 11/20/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Certara Stock (NASDAQ:CERT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Certara alerts:Sign Up Key Stats Today's Range$10.42▼$10.8650-Day Range$8.00▼$12.2252-Week Range$4.45▼$12.61Volume2.78 million shsAverage Volume2.76 million shsMarket Capitalization$1.61 billionP/E RatioN/ADividend YieldN/APrice Target$9.91Consensus RatingHold Company Overview Certara provides software and consulting services that support the development and use of medicines. Its biosimulation tools help pharmaceutical and biotechnology companies model how drugs behave in the body, assess potential treatment outcomes, and inform decisions during drug research and development. The company’s offerings include software for pharmacokinetic and pharmacodynamic modeling, clinical trial simulation, and drug development analysis. Certara also provides scientific and regulatory consulting, including support for regulatory submissions and strategies that use modeling and simulation to guide development programs. Based in Princeton, New Jersey, Certara serves pharmaceutical and biotechnology companies, regulatory agencies, and other organizations involved in life sciences around the world. Its business combines proprietary software with scientific expertise to help customers evaluate medicines and navigate development and regulatory processes.AI Generated. May Contain Errors. Read More Certara Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks30th Percentile Overall ScoreCERT MarketRank™: 1.507146860985 of 5 starsCertara scored higher than 30% of companies evaluated by MarketBeat, and ranked 729th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingCertara has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 4 buy ratings, 7 hold ratings, and 1 sell rating.Downside RiskCertara has a consensus price target of $9.91, representing about 6.1% downside from its current price of $10.55.Amount of Analyst CoverageCertara has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Certara's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth40.00% Earnings GrowthEarnings for Certara are expected to grow by 40.00% in the coming year, from $0.20 to $0.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Certara is -25.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Certara is -25.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCertara has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.92% of the float of Certara has been sold short.Short Interest Ratio / Days to CoverCertara has a short interest ratio ("days to cover") of 11.55, which indicates bearish sentiment.Change versus previous monthShort interest in Certara has recently decreased by 0.59%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCertara does not currently pay a dividend.Dividend GrowthCertara does not have a long track record of dividend growth. News and Social Media2.3 / 5News Sentiment0.74 News SentimentCertara has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Certara this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for CERT on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Certara to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Certara insiders have not sold or bought any company stock.Percentage Held by Insiders1.08% of the stock of Certara is held by insiders.Percentage Held by Institutions73.96% of the stock of Certara is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Certara's insider trading history. Receive CERT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Certara and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CERT Stock News HeadlinesCertara (CERT) Stock May Be Near Fair Value After A 63% SlumpNovember 20 at 8:38 AM | finance.yahoo.comCertara, Inc. (NASDAQ:CERT) Stock Has Average Price Target of $9.92November 18, 2026 | americanbankingnews.comYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.November 22 at 1:00 AM | Profits Run (Ad)Certara, Inc. 2026 Q3 - Results - Earnings Call PresentationNovember 9, 2026 | seekingalpha.comCertara, Inc. (CERT) Q3 2026 Earnings Call TranscriptNovember 6, 2026 | seekingalpha.comUBS Downgrades Certara to Neutral From Buy, Price Target is $13November 6, 2026 | marketscreener.comMWhy Did Certara (CERT) Shares Climb After Its Latest Update?November 6, 2026 | finance.yahoo.comCertara Inc (CERT) Q3 2026 Earnings Call Highlights: Software Growth Accelerates as Margins ExpandNovember 5, 2026 | finance.yahoo.comSee More Headlines CERT Stock Analysis - Frequently Asked Questions How have CERT shares performed this year? Certara's stock was trading at $8.81 on January 1st, 2026. Since then, CERT shares have increased by 19.8% and is now trading at $10.55. How were Certara's earnings last quarter? Certara, Inc. (NASDAQ:CERT) released its quarterly earnings results on Thursday, November, 5th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.00. The company's quarterly revenue was down 9.3% on a year-over-year basis. Read the conference call transcript. When did Certara IPO? Certara (CERT) raised $685 million in an initial public offering (IPO) on Wednesday, December 9th 2020. The company issued 33,413,250 shares at a price of $19.00-$22.00 per share. Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays and William Blair acted as the underwriters for the IPO. Who are Certara's major shareholders? Top institutional investors of Certara include State Street Corp (3.10%), Royce & Associates LP (1.93%), Boston Partners (1.51%) and Goldman Sachs Group Inc. (1.11%). Insiders that own company stock include Richard M Traynor, Leif E Pedersen and Patrick F Smith. View institutional ownership trends. How do I buy shares of Certara? Shares of CERT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Certara own? Based on aggregate information from My MarketBeat watchlists, some other companies that Certara investors own include NVIDIA (NVDA), ASML (ASML), Energy Transfer (ET), Palantir Technologies (PLTR), Super Micro Computer (SMCI), SoundHound AI (SOUN) and Tesla (TSLA). Company Calendar Last Earnings11/05/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CERT's financial health is in the Green zone, according to TradeSmith. CERT has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:CERT CIK1827090 Webwww.certara.com Phone609-716-7900FaxN/AEmployees1,576Year Founded2008Price Target and Rating Average Price Target for Certara$9.91 High Price Target$13.00 Low Price Target$6.00 Potential Upside/Downside-6.1%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($0.42) Trailing P/E RatioN/A Forward P/E Ratio37.68 P/E GrowthN/ANet Income-$1.60 million Net Margins-16.14% Pretax Margin-3.25% Return on Equity3.36% Return on Assets2.31% Debt Debt-to-Equity Ratio0.29 Current Ratio2.58 Quick Ratio2.58 Sales & Book Value Annual Sales$425.76 million Price / Sales3.78 Cash Flow$0.76 per share Price / Cash Flow13.94 Book Value$6.41 per share Price / Book1.65Miscellaneous Outstanding Shares152,543,000Free Float150,896,000Market Cap$1.61 billion OptionableOptionable Beta1.30 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:CERT) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredThe warning signs most investors see too lateDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. ...Weiss Ratings | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredRetirement balance looks fine, so why do you feel behind?Does your retirement balance look fine while you still feel like you're falling behind? On Wednesday, December...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Certara, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Certara With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.